Lunai Bioworks (LNAI) Intangibles (2012 - 2026)
Lunai Bioworks (LNAI) posted quarterly Intangibles of $119115.0 for Q1 2026, up 636.55% year-over-year from $16172.0 in Q1 2025, and down 98.0% quarter-over-quarter from $6.0 million in Q4 2025.
Lunai Bioworks (LNAI) Intangibles (2012 - 2026) Analysis & Trends
Lunai Bioworks' Intangibles history runs 15 years deep, the most recent figure standing at $119115.0 for Q1 2026.
- In Q1 2026, Intangibles rose 636.55% year-over-year to $119115.0; the TTM figure through Mar 2026 stood at $119115.0 (up 636.55% YoY), while the FY2025 annual figure was $6.0 million, down 96.26% from the prior year.
- Intangibles for Q1 2026 stood at $119115.0, down from $6.0 million in the prior quarter.
- The five-year high for Intangibles was $159.3 million in Q2 2024, with the low at $16172.0 in Q1 2025.
- The 5-year median for Intangibles is $10.8 million (2024), against an average of $41.6 million.
- The sharpest annual moves came in 2022 and 2024: Intangibles sank 99.97% in 2022, then jumped 330769.99% in 2024.
- Lunai Bioworks' Intangibles stood at $61.6 million in 2022, then plunged by 99.95% to $32641.0 in 2023, then surged by 330769.99% to $108.0 million in 2024, then sank by 94.48% to $6.0 million in 2025, then sank by 98.0% to $119115.0 in 2026.
- Business Quant data shows LNAI's Intangibles at $119115.0 in Q1 2026, $6.0 million in Q4 2025, and $6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | 5.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119,115.00 |
| Dec 31, 2025 | 5.96 Mn |
| Sep 30, 2025 | 5.96 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 16,172.00 |
| Dec 31, 2024 | 108.00 Mn |
| Sep 30, 2024 | 118.17 Mn |
| Jun 30, 2024 | 159.33 Mn |
| Mar 31, 2024 | 10.76 Mn |
| Dec 31, 2023 | 32,641.00 |
| Sep 30, 2023 | 42.61 Mn |
| Jun 30, 2023 | 54.25 Mn |
| Mar 31, 2023 | 41,095.00 |
| Dec 31, 2022 | 61.57 Mn |
| Sep 30, 2022 | 61.57 Mn |
| Jun 30, 2022 | 73.21 Mn |
| Mar 31, 2022 | 50,596.00 |
| Dec 31, 2021 | 166.46 Mn |
| Sep 30, 2021 | 166.46 Mn |
| Jun 30, 2021 | 65,906.00 |